Skip to main content
Sage Choice logoLink to Sage Choice
. 2024 Oct 21;40(1):26–38. doi: 10.1177/08830738241283171

Stress and Quality of Life of Parents of Children With POLR3-Related Leukodystrophy: A Cross-Sectional Pilot Study

Laura Lentini 1,2, Helia Toutounchi 1,2, Alexandra Chapleau 1,2, Adam Le 1,2, Simon Fournier 1,2, Fatemeh Emari 1,2, Robert Flamini 3, Andrea Rossi 4,5, Angela Gentile 6, Enrico Bertini 7, Francesco Nicita 7, Daniela Pohl 8, Sunita Venkateswaran 9, Stephanie Keller 10, Elsa Rossignol 11, Deborah Renaud 12, Danilo De Assis Pereira 13, Xiaoru Chen 1,2, Adeline Vanderver 14,15, Geneviève Bernard 1,2,16,17,18,
PMCID: PMC11590388  PMID: 39429022

Abstract

Background: RNA polymerase III (POLR3)-related leukodystrophy is a rare, neurodegenerative disorder characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism. Despite the challenges of caring for a child with POLR3-related leukodystrophy, few studies have examined parents’ disease burden. We sought to investigate quality of life and stress levels amongst parents of children with POLR3-related leukodystrophy. Methods: 43 parents of 32 children completed questionnaires on demographics, stress, quality of life, coping mechanisms, and experience of injustice. Detailed clinical data was collected from all patients. Results: Mothers (t[27] = –8.66, P < .001) and fathers (t[16] = –4.47, P < .001) had lower quality of life scores compared to the normative population, yet 80% of parents’ stress scores fell within the normal stress range. Parents’ experience of injustice scores were high (>60). Correlations were found between and within parents’ scores. Years since disease onset and certain life circumstances correlated to mothers’ quality of life scores; however, no correlation was found between modifiable factors and fathers’ quality of life scores. Helpful coping mechanisms included those that allowed parents to be involved in their child's life. Conclusions: This is the first study to assess stress and quality of life in this population. These results shed light on the importance of implementing services and social support to improve the well-being of parents.

Keywords: anxiety, quality of life, genetics, leukodystrophy, children


Leukodystrophies are a group of rare, hereditary disorders affecting the cerebral white matter of the brain. They primarily affect the pediatric population, running a progressively debilitating course leading to premature mortality. Altogether, they have a prevalence of 1:4733 live births. 1 Hypomyelinating leukodystrophies are a subset of leukodystrophies characterized by a lack of myelin production and deposition during development, and can be diagnosed based on brain MRI findings. RNA polymerase III-related leukodystrophy (POLR3-HLD; MIM: 607694, 614381, 616494) is an autosomal recessive hypomyelinating leukodystrophy caused by biallelic pathogenic variants in genes encoding subunits of RNA Polymerase III (Pol III); POLR3A, 2 POLR3B, 3 POLR1C, 4 POLR3D, 5 and POLR3K. 6 Pol III is an essential enzyme responsible for the synthesis of small noncoding RNAs, the majority of which are crucial for transcriptional control, RNA processing, ribosomal assembly, and protein translation.7,8

POLR3-related leukodystrophy, also known colloquially as 4H leukodystrophy because of its characteristic clinical features of hypomyelination, hypodontia, and hypogonadotropic hypogonadism, typically presents during childhood with delayed milestones and/or motor regression. Cerebellar features typically predominate, with progressive ataxia, dysmetria, and dysarthria, while pyramidal and extrapyramidal (ie, dystonia9,10) signs are usually less prominent. Cognitive involvement is common, but variable in severity, and may include learning and intellectual disabilities, behavioral abnormalities, and/or cognitive regression.11,12 Endocrine manifestations (ie, delayed/arrested/absent puberty, or short stature 13 ) and ocular anomalies (typically myopia) are often seen. 14 POLR3-related leukodystrophy is known to range in severity, spanning from milder forms with late-onset manifestations to more severe early presentations in infants with various defined phenotypes, depending on the specific combination of mutations.6,11,12,15-19 Although disease manifestations can be variable, patients with biallelic variants in POLR3A have been associated with a more rapid disease progression compared to individuals with variants in POLR3B. 11 To date, no therapeutic interventions are available for POLR3-related leukodystrophy beyond symptom management.

Children with POLR3-related leukodystrophy require constant yet ever-evolving care because of the multisystemic and gradual progression of the disease. Consequently, as seen in other rare diseases, parents face increased parental responsibilities combined with the challenges of accessing specialized health care and the emotional burden of their child's disease progression. 20 Indeed, caring for a chronically ill child can have a substantial impact on a parent’s stress levels and quality of life (QoL), placing these parents at an elevated risk for adverse mental health outcomes such as anxiety or depression. 21 This, in turn, can impact a parent's ability to effectively navigate and cope with their child's disease,22-25 influencing their interactions and responsiveness toward their child, thereby affecting their child's growth and behavior. 26 Thus, identifying modifiable factors significantly influencing parental quality of life and stress are vital for improving outcomes for patients, their parents, and families. Caregiver susceptibility to increased stress and lower quality of life is determined by a variety of psychosocial, environmental, and personal factors. These include personal circumstances, 20 the availability of support systems,27,28 the frequency of beneficial vs maladaptive coping mechanisms used,29-31 and an individual's own appraisal of his or her situation, framed as perceived injustice.23,32,33 Further, the nature of the child's disease, including disease severity and duration, degree of impairment, and the presence of specific clinical features such as physical impairments,34-36 sleep,35,37 and behavioral issues 34 have been demonstrated to influence parental stress levels and overall quality of life.

Despite POLR3-related leukodystrophy's progressive nature and the elevated risks associated with lower quality of life and higher stress, there is limited knowledge on the effects of this disease in this parent population. A pilot study of patients with leukodystrophies and genetically determined leukoencephalopathies reported poorer health-related quality of life 38 and higher parental stress levels compared to families with healthy children. 39 Furthermore, clinical variables such as the degree of functional impairment and behavior were associated with increased maternal stress levels, clinical characteristics commonly associated with POLR3-related leukodystrophy, suggesting POLR3-related leukodystrophy parents may be at risk of high stress. 39 In this study, we assessed parents’ quality of life and stress levels and identified clinical, psychosocial, and personal factors that may impact these levels.

Patients and Methods

Participants

The study sample consisted of parents of children with POLR3-related leukodystrophy recruited from the Leukodystrophy and Neurometabolic Diseases Clinic at the Montreal Children's Hospital, or who were referred from international collaborators between September 2021 and December 2022. Inclusion criteria included parents of patients with a confirmed POLR3-related leukodystrophy molecular diagnosis, parents that were either considered primary or secondary caregivers, and parents who lived with their affected child(ren). Exclusion criteria included parents who were not literate in English or French. This study was approved by the Research Ethics Board of the McGill University Health Centre Research Institute (11-105-PED, 2019-4972). All participants were informed about the research study, and written informed consent was obtained. All data was collected, recorded, and assessed in a standardized fashion by researchers at the Montreal Children's Hospital.

Questionnaires

Several questionnaires and their instructions were shared in-person or sent electronically to all parents, and were available in English or French. These questionnaires included a demographics questionnaire; the PedsQL Family Impact Module, 40 which measures the impact of pediatric chronic health conditions on parents’ quality of life; the Parenting Stress Index 4th Edition (PSI), 41 the Stress Index for Parents of Adolescents (SIPA), 42 or the Parental Stress Scale (PSS), 43 which assess the stress levels through one's parenting role and relationship with children, adolescents, or adult children, respectively; the Coping Health Inventory for Parents (CHIP), 44 which focuses on parents’ methods for coping with the responsibilities of a child with a chronic medical condition, and the Injustice Experiences Questionnaire (IEQ), 45 which determines the causes and consequences of injustice appraisals in situations of those with physical and mental health conditions (Table 1). These questionnaires were chosen based on their strong validity, reliability, and consistent use in other studies with populations with similar chronic illnesses.38,46-51

Table 1.

List of Questionnaires. a

Measurement Questionnaire Applicable age range
Demographic information
  • Demographic Questionnaire

All ages
Stress
  • Parenting Stress Index 4th Edition (PSI)

<12 y
  • Stress Index for Parents of Adolescents (SIPA)

12-18 y
  • Parental Stress Scale (PSS)

>18 y
Quality of life
  • Family Impact Module (FIM)

All ages
Coping mechanisms
  • Coping Health Index for Parents (CHIP)

All ages
Experiences of injustice
  • The Injustice Experiences Questionnaire (IEQ)

All ages
a

This table includes a list of questionnaires used in this study, what each questionnaire measures, and the age groups for each questionnaire.

Clinical History

Updated medical records of clinical visits within 1 to 6 months prior to the questionnaires’ administration were reviewed. Recorded clinical information included age of onset, years since diagnosis, relevant clinical features such as spasticity, tremor, dystonia, ataxia, dysmetria, dysarthria, sialorrhea, dysphagia, anarthria, delayed cognitive development, behavioral issues, fatigue, gait abnormality, wheelchair use, feeding tube dependency, the number of features present, and scores for severity scales of gross motor, fine motor, eating and swallowing, and speech (ie, Gross Motor Function Classification System, 52 Manual Ability Classification System, 53 Eating and Drinking Ability Classification System, 54 and Communication Function Classification System 55 ) (Table 2).

Table 2.

List of Severity Scales. a

Outcome assessment Populations for which the assessment has been validated Age range
Gross Motor Function Classification System (GMFCS) CP 52 , MLD 56 , AGS57,58 2-18 y
Manual Ability Classification System (MACS) CP 53 , AGS 59 4-18 y
Eating and Drinking Classification System (EDACS) CP 54 3-18 y
Communication Function Classification System (CFCS) CP 55 , AGS 58 2-18 y

Abbreviations: AGS, Aicardi-Goutières Syndrome; CP, Cerebral Palsy; MLD, Metachromatic leukodystrophy.

a

This table includes a list of severity scale assessments, the populations for which the assessment has been validated for, and the age ranges for each assessment.

Statistical Analysis

Statistical analyses were performed using SPSS, version 26.0. Parental stress and quality of life scores were the primary outcomes. Unpaired t tests were conducted to compare mothers’ and fathers’ stress percentile scores, and one-sample 2-tailed t tests were conducted to compare mothers’ and fathers’ raw stress, PedsQL Family Impact Module (and specific domains) and Parental Stress Scale scores with their respective normative population samples. The total mean score of each coping mechanism was also considered. Stress percentile scores and Injustice Experiences Questionnaire scores were considered on their respective ranges. Pearson correlation coefficients were used to study the relationship between continuous variables, different coping mechanisms, and other parental questionnaire scores along with mothers’ and fathers’ stress percentile and PedsQL Family Impact Module scores. Chi square analyses were performed to compare mothers’ stress percentile scores with children's clinical features and certain parental life circumstances. Alpha was set to .05.

Results

Population Characteristics

A total of 43 caregivers (26 biological mothers, 1 foster mother, and 16 fathers, including 3 families with 2 affected children) participated in the study. The characteristics of the parent population are summarized in Table 3. Most parents reported being in a marital or common law relationship (33 of 43; 77%). The education level was statistically equivalent between genders, with most parents reporting postsecondary-level education (35 of 43; 81%). Employment status differed between parents, with more fathers reporting employment (14 of 16; 88%) compared to mothers (15 of 27; 56%); however, more than half of the total cohort was employed (29 of 43; 63%). All mothers presented as the primary caregiver.

Table 3.

Parent Characteristics. a

Demographics Mother/ father, n Mother/ father, %
Married 17/14 65/88
Common law 1/1 4/6
Single 7/1 27/6
Divorced 1/0 6/–
Unemployed 9/1 35/6
Retired 2/2 8/13
Employed 15/14 56/88
Postsecondary education 23/12 88/75
High school education 3/4 12/25
Household income less than $50 000 1/1 4/7
Household income between $50 000-100 000 12/7 46/44
Household income >$100 000 13/8 50/50
a

This table summarizes parental demographics including relationship status, education, household income, as well as life circumstances.

32 patients (16 males and 16 females) ranging from 2 to 40 years old with POLR3-related leukodystrophy were included in the study. Characteristics of the patient population are summarized in Table 4. Most patients in the cohort were aged 12 years old or younger (12 of 32; 38%), compared to patients aged 12-18 years (10 of 32; 31%) or >18 years (10 of 32; 31%). The majority of children had biallelic pathogenic variants in POLR3A (14 of 32; 44%) and POLR3B (16 of 32; 50%), with only a minority with biallelic variants in POLR1C (2 of 32; 6%). Age of disease onset primarily occurred between 1 and 5 years (20 of 32; 63%). At the time of questionnaire completion, the time elapsed since diagnosis varied from 0 to 5 years (11 of 32; 34%), 5 to 10 years (7 of 32; 22%), 10 to 15 years (3 of 32; 9%), and >15 years (6 of 32; 19%). The most prevalent clinical features reported were abnormal gait (21 of 32; 66%), ataxia (20 of 32; 63%), delayed cognitive development (19 of 32; 59%), and wheelchair use (19 of 32; 59%). Classification median scores for Gross Motor Function Classification System, Eating and Drinking Ability Classification System, and Manual Ability Classification System were 4, indicating severe functional impairment.

Table 4.

Patient Characteristics.

Patients N = 32 Percentage
Sex
 Males 16 50%
 Females 16 50%
Child age group (range)
 <12 years old 12 38%
 12-18 years old 10 31%
 +18 years old 10 31%
Genotype
POLR3A 14 44%
POLR3B 16 50%
POLR1C 2 6%
Age at disease Onset
 <1 year old 6 19%
 1-5 years old 20 63%
 5-10 years old 2 6%
 10 + years old 2 6%
 Unknown 2 6%
Number of Years Since Disease Diagnosis
 0-5 years 11 34%
 5-10 years 7 22%
 10-15 years 3 9%
 15 + years 6 19%
 Unknown 5 16%
Clinical Features Present
 Abnormal Gait 21 66%
 Delayed Cognitive Development 19 59%
 Fatigue 3 9%
 Gross Motor Function Issues 7 22%
 Fine Motor Function Issues 4 13%
 Spasticity 14 44%
 Tremor 18 56%
 Dystonia 10 31%
 Ataxia 20 63%
 Dysmetria 7 22%
 Dysarthria 12 38%
 Sialorrhea 7 22%
 Dysphagia 11 34%
 Wheelchair Use 19 59%
 Feeding Tube 9 28%
 Anarthria 6 19%
 Behavioral Issues 5 16%
Scales N = 30 Median (IQR)
GMFCS 26 4 (1,5)
MACS 15 4 (1,5)
EDACS 21 4 (1,5)
CFCS 20 3 (1,5)

Abbreviations: CFCS, Communication Function Classification System; EDACS, Eating and Drinking Ability Classification System; GMFCS, Gross Motor Function Classification System; MACS, Manual Ability Classification System.

a

This table summarizes the characteristics of patients who participated in this study, such as sex, age group, mutated genes, age of clinical feature onset, number of years since diagnosis, present clinical features of the children, and number of completed scores per child as well as median scores of each severity scale.

PedsQL Family Impact Module Dimension Scores (Quality of Life Measurement)

The average total PedsQL Family Impact Module score (which included domains such as physical, emotional, social and cognitive functioning, communication, worry, daily activities, family relationships, parent health-related quality of life, and family functioning) for mothers was 48.36 ± 16.40, and 52.56 ± 20.72 for fathers. Lower scores on the PedsQL Family Impact Module indicate poorer quality of life or greater negative family impact. 60 These average scores were statistically significantly lower compared to the average total PedsQL Family Impact Module score of a normative population (75.70 ± 14.50) found in the literature. 59 The selection of this population was based on demographic similarities with our cohort. Therefore, mothers (t[27] = –8.66, P < .001) and fathers (t[16] = –4.47, P < .001) had statistically significantly lower quality of life scores compared to the normative population (Table 5). Analysis of each domain included within the PedsQL Family Impact Module questionnaire revealed that both mothers and fathers had significantly high mean scores in the family relationship domain (M(mother) = 62.41, M(father) = 60.67), indicating that this domain positively affects their quality of life. Conversely, both parents had significantly low mean scores in the worry domain (M(mother) = 34.71, M(father) = 38.70), indicating that this domain negatively impacts their quality of life.

Table 5.

Descriptive Statistics for Questionnaire Scores. a

Questionnaire scores Mean ± standard deviation Normative sample t value P value Effect size (d)
PSI/SIPA (raw scores)
 Mothers 235.11±63.39 221.10 ± 59.60 221.10 .11 0.22
 Fathers 242.45±64.09 228.20 ± 61.70 228.2 .13 0.27
PSI/SIPA (%ile)
 Mothers 60.65 ± 27.17 N/A
 Fathers 62.27 ± 26.91
PSS
 Mothers 10.33 ± 2.80 27.78 ± 6.28 −15.38 <.001* −5.81
 Fathers 12.80 ± 5.54 27.78 ± 6.28 −6.05 .002* −2.70
FIM
 Mothers 48.36± 16.40, 75.70 ± 14.50 −8.66 <.001* −1.67
 Fathers 52.56 ± 20.72 75.70 ± 14.50 −4.47 <.001* −1.12
IEQ
 Mothers 23.44 ± 7.83 N/A
 Fathers 22.82 ± 11.52 N/A
CHIP
 Mothers (domain 1) 34.96 ± 11.81 N/A
 Fathers (domain 1) 31.06 ± 12.43 N/A
 Mothers (domain 2) 35.14 ± 9.93 N/A
 Fathers (domain 2) 36.19 ± 9.42 N/A
 Mothers (domain 3) 14.96 ± 5.60 N/A
 Fathers (domain 3) 14.00 ± 5.99 N/A
Helpful vs unhelpful coping mechanisms
 Investing myself in my children 2.80 ± 0.40 N/A
 Doing things with my children 2.63 ± 0.88 N/A
 Doing things together as a family (involving all members of the family) 2.60 ± 0.49 N/A
 Allowing myself to get angry 1.43 ± 0.49 N/A
 Getting other members of the family to help with chores and tasks at home 1.33 ± 0.85 N/A
 Believing that my child(ren) will get better 1.48 ± 1.15 N/A

Abbreviations: CHIP, Coping Health Inventory for Parents; FIM, PedsQL Family Impact Module; IEQ, Injustice Experiences Questionnaire; PSI/SIPA, Parenting Stress Index / Stress Index for Parents of Adolescents; PSS, Parental Stress Scale

a

The means and standard deviations were obtained for the questionnaire scores of mothers and fathers, as well as the normative sample (when applicable). One-sample t tests were performed on the PSI/SIPA raw scores, PSS scores, and FIM scores, and the effect sizes were represented by Cohen d.

*Statistically significant (P < .05).

Parenting Stress Index / Stress Index for Parents of Adolescents / Parental Stress Scale Dimension Scores (Stress Measurement)

When assessing stress levels, both mothers’ (221.10 ± 59.60) and fathers’ (228.20 ± 61.70) average total raw Parenting Stress Index 4th Edition / Stress Index for Parents of Adolescents scores were comparable to the normative samples. 41 These raw scores were then transformed into a percentile score. 70% of mothers and 73% of fathers had a score above the 50th percentile, where the percentile represents a score that is equal to or greater than the percentage of a standardized and representative normative sample. Percentile scores that fall between the 16th and 84th percentiles are considered within the normal range, scores between the 85th and 89th percentiles are considered high, and scores at the 90th percentile and above are within the clinically significant range. 41 Consequently, a majority of caregivers reported stress levels within the normal range (74% of mothers, 81% of fathers), with a subset falling within the high stress level range (15% of mothers, 9% of fathers), and a smaller subset within the clinically significant stress level range (7% of mothers, 9% of fathers). For parents of adult children, both mothers (t[7] = –15.38, P < .001) and fathers (t[5] = –6.05, P = .002) exhibited statistically significantly lower Parental Stress Scale scores compared to the normative sample 61 as outlined in Table 5.

Predictors of Stress and Quality of life: Injustice Experiences Questionnaire and Coping Health Inventory for Parents Dimension Scores

Parents reported variable outcomes on the Injustice Experiences Questionnaire, with the average parental score falling within or on the cusp of the average range (14-22). Specifically, mothers mostly fell within the average (14-22) to very high (>34) ranges, whereas fathers’ scores ranged from very low (<5) to very high (>34). For the Coping Health Inventory for Parents questionnaire scores, coping mechanisms found to be the most helpful included investing oneself in their children (M= 2.80 ± 0.40), doing activities with one's children (M= 2.63 ± 0.88), and doing activities together as a family (M= 2.60 ± 0.49). Conversely, the least helpful coping mechanisms included allowing oneself to get angry (M= 1.43 ± 0.49), getting other members of the family to help with chores and tasks at home (M= 1.33 ± 0.85), and believing that one's child(ren) will get better (M= 1.48 ± 1.15).

There is no significant difference between the scores of mothers and fathers both within couples or across families in regards to the Parenting Stress Index 4th Edition / Stress Index for Parents of Adolescents, Parental Stress Scale, PedsQL Family Impact Module, Injustice Experiences Questionnaire, or Coping Health Inventory for Parents questionnaires. All results are outlined in Table 5.

Relationship Between Sociodemographic and Psychosocial Factors, Stress and Quality of Life

To explore the intricate multivariate relationship between stress, quality of life, and the sociodemographic and psychosocial profiles investigated, Pearson correlations were conducted for each category. Mothers’ PedsQL Family Impact Module scores were found to correlate with their Injustice Experiences Questionnaire scores (r = –0.52, P = .01), Parenting Stress Index scores (r = –0.56, P = .02), as well as fathers’ PedsQL Family Impact Module scores (r = 0.74, P = .002) and Injustice Experiences Questionnaire scores (r = –0.71, P = .01). These findings indicate that there is a correlation between mothers’ quality of life and both parental experiences of injustice, stress levels, and fathers’ quality of life. Similarly, fathers’ PedsQL Family Impact Module scores were found to negatively correlate with their Injustice Experiences Questionnaire scores (r = –0.84, P < .001) and mothers’ Injustice Experiences Questionnaire scores (r = –0.80, P < .001), indicating a correlation between fathers’ quality of life and both parental experiences of injustice.

Moreover, mothers’ and fathers’ Parenting Stress Index percentile scores were positively correlated (r = 0.89, P < .001), indicating mutual influence between parental stress levels. Statistically significant correlations were also found between mothers’ Parenting Stress Index scores and Coping Health Inventory for Parents scores for the following coping mechanisms: doing things with family relatives (r = 0.80, P = .02), trying to maintain family stability (r = 0.51, P = .02), involvement in social activities with friends (r = 0.79, P = .02), time spent alone (r = –0.55, P = .02), and purchasing gifts for oneself and/or other family members (r = –0.62, P = .01), determining that mothers’ stress levels can be influenced by the type of coping mechanism practiced. Additionally, statistically significant correlations were found between mothers’ PedsQL Family Impact Module scores and Coping Health Inventory for Parents scores for the following coping mechanisms: talking with the doctor about my concerns about my child(ren) with the medical condition (r = 0.45, P < .05), talking over personal feelings and concerns with a spouse (r = 0.46, P < .05), doing things with my children (r = 0.45, P < .05), and telling myself that I have many things I should be thankful for (r = 0.44, P < .05).

When exploring correlations with clinical features and medical history, a positive correlation was found between mothers’ quality of life scores and years since disease diagnosis (r = 0.49, P = .02). Complete results are listed in Table 6.

Table 6.

Pearson Correlation for Mothers’ and Fathers’ Stress and Quality of Life Scores. a

Mothers’ PSI/SIPA stress percentile Mothers’ FIM score Fathers’ PSI/SIPA stress percentile Fathers’ FIM score
Questionnaires
PSI/SIPA
  Mothers r = −0.56, P = .02* r = 0.89, P < .001* r = –0.64, P = .05
  Fathers r = 0.89, P < .001* r = −0.38, P = .28 r = −0.60, P = .09
FIM
  Mothers r = −0.56, P = .02* r = −0.38, P = .28 r = 0.74, P = .002*
  Fathers r = −0.64, P = .05 r = 0.74, P = .002* r = −0.60, P = .09
IEQ
  Mothers r = 0.21, P = .41 r = −0.52, P = .01* r = 0.27, P = .44 r = −0.80, P < .001*
  Fathers r = 0.16, P = .65 r = −0.71, P = .01* r = 0.42, P = .22 r = −0.84, P < .001*
PSS
  Mothers r = 0.25, P = .59 r = −0.18, P = .77
  Fathers r = 0.37, P = .54 r = −0.05, P = .94
CHIP b
  Mothers’ domain 1 r = −0.18, P = .48 r = 0.30, P = .16 r = −0.19, P = .60 r = −0.19, P = .60
  Fathers’ domain 1 r = −0.14, P = .71 r = 0.03, P = .91 r = −0.13, P = .74 r = −0.13, P = .74
  Mothers’ domain 2 r = −0.36, P = .13 r = 0.31, P = .15 r = −0.26, P = .46 r = −0.05, P = .94
  Fathers’ domain 2 r = −0.17, P = .66 r = −0.30, P = .32 r = −0.25, P = .51 r = −0.25, P = .51
  Mothers’ domain 3 r = −0.17, P = .50 r = 0.17, P = .45 r = −0.26, P = .46 r = −0.26, P = .46
  Fathers’ domain 3 r = −0.33, P = .38 r = −0.15, P = .61 r = −0.25, P = .51 r = −0.25, P = .51
Continuous variables
 Age of feature onset r = 0.18, P = .45 r = −0.270, P = .17
 Years since diagnosis r = −0.17, P = .49 r = 0.49, P = .02*
 Current age r = −0.08, P = .75 r = 0.28, P = .18
 Number of siblings r = −0.05, P = .84 r = 0.06, P = .78
 Number of features r = 0.16, P = .51 r = 0.25, P = .20
 Number of life stress circumstances r = 0.09, P = .72 r = −0.17, P = .50
Coping mechanisms
 Doing things with family relatives r = 0.80, P = .02* r = −0.09, P = .79
 Trying to maintain family stability r = 0.51, P = .02* r = −0.34, P = .25
 Involvement in social activities with friends r = 0.79, P = .02* r = 0.18, P = .58
 Getting away by myself r = −0.55, P = .02* r = 0.05, P = .88
 Purchasing gifts for oneself and/or other family members r = −0.62, P = .01* r = −0.53, P = .08
 Talking with the doctor about my concerns about my child(ren) with the medical condition r = −1.35, P = .58 r = 0.45, P < .05
 Talking over personal feelings and concerns with spouse r = −0.07, P = .76 r = 0.46, P < .05
 Doing things with my children r = −0.32, P = .19 r = 0.45, P < .05
 Telling myself that I have many things I should be thankful for r = 1.43, P = .55 r = 0.44, P < .05

Abbreviations: CHIP, Coping Inventory for Parents; FIM, PedsQL Family Impact Module; IEQ, Injustice Experiences Questionnaire; PSI/SIPA, Parental Stress Index/Stress Index for Parents of Adolescents; PSS, Parental Stress Scale.

a

Pearson correlations were performed (results presented by r) for mothers’ and fathers’ PSI/SIPA and FIM scores, clinical features, and coping mechanisms (all other coping mechanisms not listed did not reach statistical significance). Dashes indicate that the correlation could not be performed because of similarities in the variables, or not enough data was available to render a correlational analysis.

b

CHIP domain 1 indicates “maintaining family integration, cooperation, and an optimistic definition of the situation.” 44 CHIP domain 2 indicates “maintaining social support, self-esteem, and psychological stability.” 44 CHIP domain 3 indicates “understanding the medical situation through communication with other parents and consultation with medical staff.” 44

*Statistically significant (P < .05).

A χ2 analysis showed statistically significant relationships between Parenting Stress Index stress percentile scores of mothers and certain parental life circumstances such as debt (for mothers), χ2(1, n = 15) = 12.94, P = .01; substantial income decrease (for fathers), χ2(1, n = 8) = 14.44, P = .04; taking care of an ill parent (for fathers), χ2(1, n = 17) = 11.91, P < .01; suffering from an injury or chronic health condition (for fathers), χ2(1, n = 17) = 11.91, P = .01; and having a child enter a new school (for mothers), χ2(1, n = 15) = 16.35, P = .01. There is no statistically significant relationship found for fathers’ Parenting Stress Index stress percentile scores. Multivariate analysis between parental scores and severity scores could not be performed because of the small sample size. Complete results are shown in Table 7.

Table 7.

Summary of χ2 Analysis Results for Categorical Variables. a

Mothers’ stress percentile score
Categorical variables χ2 value P value Cramer V
Abnormal gait 17.00 .32 1.00
Delayed cognitive development 56.25 .29 0.97
Fatigue 13.00 .37 1.00
Spasticity 60.00 .18 1.00
Tremor 15.51 .42 0.93
Dystonia 17.00 .26 1.00
Ataxia 14.22 .43 0.92
Dysmetria 14.81 .39 0.93
Dysarthria 15.11 .44 0.92
Sialorrhea 15.11 .44 0.92
Dysphagia 16.95 .39 0.94
Wheelchair use 15.24 .51 0.90
Feeding tube 14.37 .57 0.87
Anarthria 20.00 .27 1.00
Behavioral issues 14.37 .57 0.87
GMFCS 59.22 .36 0.93
EDACS 55.00 .36 0.96
MACS 34.13 .41 0.94
CFCS 58.40 .25 0.96
Marital status 13.56 .48 0.48
Education 23.43 .61 0.61
Employment status 13.40 .38 0.38
Household income 25.63 .36 0.36
Mothers’ debt 12.94 .01* 0.89
Fathers’ substantial income decrease 14.44 .04* 0.80
Fathers taking care of an ill parent 11.91 .003* 0.84
Fathers suffering from an injury or chronic health condition 11.91 .01* 0.84
Mothers having a child enter a new school 16.35 .01* 0.75

Abbreviations: CFCS, Communication Function Classification System; EDACS, Eating and Drinking Ability Classification System; GMFCS, Gross Motor Function Classification System; MACS, Manual Ability Classification System.

a

χ2 analysis was conducted for each categorical variable. Cramer V represents the strength of the relationship between variables. Categorical variables such as the child's clinical features and parents’ demographics were not found to contribute to mothers’ stress percentile scores (P > .05). Some parental life stress situations were found to contribute to mothers’ stress percentile scores. Relationships between the variables listed and fathers’ stress percentile scores were omitted because of missing data, and other parental life stress situations were omitted to keep the table succinct; however, all situational life factors that were excluded were not found to contribute to mothers’ stress percentile scores (P > .05). Analysis between fathers' scores and severity scores could not be performed because of the small sample size.

*Statistically significant (P < .05).

Discussion

Caring for children with POLR3-related leukodystrophy poses multifaceted challenges because of their child's ever-evolving symptoms and the progressive nature of their disease. Our study investigated the impact of caregiving on self-reported stress and quality of life, as well as their inter-relationships and determinants, among parents of children with POLR3-related leukodystrophy. Overall, our cohort exhibited stress levels within the normal range, but lower quality of life compared with the normative samples, highlighting the importance of considering and supporting caregiver well-being in POLR3-related leukodystrophy disease management.

Interestingly, approximately 80% of our cohort exhibited stress percentile scores within the normal range, contrasting results found in previous studies.62-66 Stress is a subjective experience that can only be measured in relation to previous experiences, and usually fluctuates over time. Often, feelings of heightened stress will coincide with moments of shock from the novelty of the situation, uncertainty, or circumstantial instability. In our cohort, the average time elapsed since diagnosis with POLR3-related leukodystrophy was 11 years, indicating parents had sufficient time to adapt to their child's condition and care plan, potentially contributing to extended periods of stability and thereby lowering stress levels to normal ranges. This study would need to be expanded to more recently diagnosed individuals to explore this explanation. Additionally, factors such as access to a Leukodystrophy Center of Excellence and availability of resources may be a reason for contributing to normal stress scores, as our cohort is being followed at specialized leukodystrophy centers with knowledge in leukodystrophy care and research that also offer resources (ie, receiving adaptable equipment for their child or financial support). These factors may alleviate some of the challenges of caring for a child with this disease. Notably, parental stress did not correlate with the child's clinical features or disease progression, potentially because of the minimal behavioral issues observed in our cohort and the generally happy nature of children (mentioned by parents) affected by this disease. However, a larger study with patients with greater symptom heterogeneity may be needed to validate this finding. Although life stressors did not correlate significantly with parental stress level, parents with clinically significant stress levels were also more likely to have experienced increased debt or financial issues,67,68 personal medical issues, 69 and/or starting a new job, all of which are factors known to impact stress. This suggests that although parents may be well-adjusted to their life circumstances and caregiving responsibilities, they may be more sensitized to stressful life events, explaining the coincidence of these factors in the clinically stressed group.

Despite the relatively normal stress levels among our cohort, parents of children with POLR3-related leukodystrophy had significantly lower quality of life than the normative sample, primarily in domains relating to feelings of worry. Parents reported significant distress associated with the child's illness and treatments, how others perceived their child's illness, the future of their child, and the impact of the illness on the family unit. Feelings of worry and apprehension are common among parents of children with chronic diseases,70,71 potentially because of the paucity of information regarding long-term prognosis as well as the lack of supportive interventions offered. Constant worrying by the parent for their ill child can place these parents at high risk for developing mood-related disorders, most commonly, anxiety and depression.70,72 Despite the overall low quality of life, family relationships remained unaffected, suggesting that a strong family unit can promote parental well-being. Cohesive familial functioning is associated with high levels of family support and resilience which are protective factors for both stress and quality of life. 73

Although no specific disease characteristics were associated with quality of life scores, time elapsed since diagnosis was an important predictor of increased quality of life in mothers. Diagnosis is a challenging and stressful time for a caregiver, as one must process new and potentially upsetting information and adapt to novel care plans. Moreover, although POLR3-related leukodystrophy is a neurodegenerative disorder, progression can be relatively slow, contributing to perceived stability and adaptation to the situation, ultimately improving quality of life. This correlation was not found in fathers, however, which may reflect the mothers’ role as the primary caregiver. Certain psychosocial factors were found to influence quality of life in POLR3-related leukodystrophy parents. Although parents reported diverse feelings of injustice or unfairness of their situations, parents who perceived more injustice within their situations also reported lower quality of life. Greater perceived experiences of injustice are associated with feelings of blame for, irreparability of, and repetitive thought about their child's situation, perpetuating the cycle of injustice and leading to feelings of isolation and loss. 45 Furthermore, the use of specific adaptive coping mechanisms was found to predict higher maternal quality of life. Coping strategies involving speaking or discussing one's thoughts, feelings, and decisions with others regarding their child were associated with improved quality of life. This is not surprising as talk therapies and promoting emotional expression is a known and effective therapeutic strategy to improving one's well-being. 74 Although not predictive of increased quality of life, other helpful coping mechanisms for parents included those centered around involvement in their children's lives, such as spending time and completing activities together. Conversely, the least helpful coping mechanisms involved feelings of anger, hope that the child will improve, and asking other family members to help around the house—coping mechanisms that did not have a direct effect on the child's condition.

An overall limitation of this study was the relatively small population size. Although these numbers are acceptable given the rarity of POLR3-related leukodystrophy, having a larger sample size may allow for more significance in the results and the ability to draw stronger conclusions. One recommendation for future studies would be to use a longitudinal mixed-methods quantitative and qualitative approach to capture the evolution of this population over time. Parental stress and poor quality of life in our population are hypothesized to be at its peak at the time of diagnosis and at the end of life, with fluctuations throughout life as a patient's health status and parents’ and family's life situation changes, which can also affect obtained results. We identified some contributing factors to this but could not obtain granular information as to why parents answered as they did. Although a few parents sent us explanations that complemented their results, a formal qualitative research approach would allow us to understand the entirety of parents’ situations and may further help us draw conclusions from these results. Lastly, the fact that questionnaires were only available in English and French may have excluded participants who speak other languages, potentially overlooking individuals at higher risk of stress and low quality of life. However, families from several countries within North America, Europe, and Africa were included to address this limitation, allowing for the best possible chance of both diversifying and generalizing the sample.

Conclusion

Our study indicates that parents of children with POLR3-related leukodystrophy are at risk of low quality of life, but not necessarily high stress levels. Time elapsed since diagnosis, feelings of perceived injustice, and the use of adaptive coping mechanisms were found to significantly predict quality of life in this population. We highlight the importance of early quality of life interventions for newly diagnosed families, which may include psychological, 75 educational, 76 or community/social group-based support,76,77 access to services pertaining to their child's health, 76 or financial resources 78 when necessary, which have been shown to improve quality of life outcomes for families coping with an array of chronic diseases. These findings pinpoint specific areas requiring support, including implementing effective communication strategies for caregivers and devising approaches to alleviate a caregiver's worries about their child's health and prognosis. Additionally, our results importantly show that although quality of life and stress may be interrelated, they are not the same entity and therefore must both be taken into account when assessing overall parental well-being. A larger longitudinal study on parental stress levels and quality of life throughout their child's disease would be an interesting future path and beneficial to further our understanding of how POLR3-related leukodystrophy can impact caregivers.

Acknowledgments

The author would like to thank all patients and their families for their participation in this study.

Footnotes

Author Contributions: LL and GB contributed to the study design, and LL conducted the study and wrote the first draft of the manuscript. AC contributed to drafting the manuscript. HT, SF, AL, and FE aided in the recruitment of participants. SF translated questionnaires. LL and XC performed the statistical analyses. GB supervised the entire study. All authors reviewed the manuscript for intellectual content and approved the final version.

The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: EB has been a consultant for Orchard Therapeutics, and Advisory Board for Novartis, PTC, Biogen, Pfizer, Roche. SK is a site investigator for the Ionis Alexander disease clinical trial (2022-present) and BioMarin long-term extension study for CLN2 patients treated with Brineura (2022-present). She was also a consultant for Veristat regarding MLD (2022) and is on the board of directors for the United Leukodystrophy Foundation. ER is a consultant for Taysha Gene Therapies (2023-present) and Acadia (2023-present). She is the PI on the REVEAL trail for Rett syndrome by Taysha Gene Therapies (2022-present). She is/was a subinvestigator on a therapeutic trial by BioMarin (2021-present), Glaxo Smith Kline (2015-2016), Pfizer (2017-2018), and Acadia (2020-2021). AV receives funding from Ionis, Sana, Illumina, Orphan Disease Center, Homology, Affinia, Sanofi, Orchard therapeutics, Takeda, Biogen, Boehringer Ingelhiem, Eli Lilly, Synaptix Bio, and PMD Foundation without any personal compensation. GB is/was a consultant for Orchard Therapeutics (2023), Passage Bio Inc (2020-2022), and Ionis (2019). She is/was a site investigator for the Alexander's disease trial of Ionis (2021-present), Metachromatic leukodystrophy of Shire/Takeda (2020-2021), Krabbe (2021-2023), and GM1 gene therapy trials (2021-present) of Passage Bio, GM1 natural history study from the University of Pennsylvania sponsored by Passage Bio (2021-present) and Adrenoleukodystrophy/Hematopoietic stem cell transplantation natural history study of Bluebird Bio (2019), and a site subinvestigator for the MPS II gene therapy trial of Regenxbio (2021-present) and the MPS II clinical trial of Denali (2022-present). She has received unrestricted educational grants from Takeda (2021-2022). All other authors did not have any potential conflicts of interest with respect to the research or publication of this article.

Funding: The authors discloses receipt of the following financial support for the research of this article: This work was supported by the Montreal Children's Hospital Foundation (Estate of Daphne Dale Townsend) as well as the Fondation Les Amis d’Elliot and the Fondation Le Tout pour Loo. LL has received the Neuroscience Recruitment Grad Excellence Award from McGill University (2021-2022), as well as the RI-MUHC Studentship Competition Award from the Research Institute of the McGill University Health Centre (RI-MUHC) (2022). AC has received a Doctoral Research Award from the Canadian Institutes of Health Research (2022-2025), a Doctoral Fellowship Award from FRQS (2025-2026), the Healthy Brains, Healthy Lives (HBHL) Master's Fellowship (2019-2021), and the Fondation du Grand défi Pierre Lavoie Master's Scholarship (2019-2020). AL has received the IPN Internal Studentship Award (2023), as well as the RI-MUHC Studentship Competition Award from the Research Institute of the McGill University Health Centre (RI-MUHC) (2023). EB and FN are members of the European Reference Center ERN RND; both EB and FN have received financial support from the Italian Ministry of Health and they were awarded with a Research Grant of the PMD Foundation. AV was supported by a grant from the Yaya Foundation and also from the U54 NS115052 NCATS/NINDS. GB has received the Clinical Research Scholar Junior 1 Award from the Fonds de Recherche du Quebec-Santé (FRQS) (2012-2016), the New Investigator Salary Award from the Canadian Institutes of Health Research (2017-2022), and the Clinical Research Scholar Senior award from the FRQS (2022-2025). All other authors did not receive any financial support for the research or publication of this article.

References

  • 1.Bonkowsky JL, Nelson C, Kingston JL, Filloux FM, Mundorff MB, Srivastava R. The burden of inherited leukodystrophies in children. Neurology. 2010;75(8):718-725. doi: 10.1212/WNL.0b013e3181eee46b [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bernard G, Chouery E, Putorti ML, et al. Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am J Hum Genet. 2011;89(3):415-423. doi: 10.1016/j.ajhg.2011.07.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Tétreault M, Choquet K, Orcesi S, et al. Recessive mutations in POLR3B, encoding the second largest subunit of pol III, cause a rare hypomyelinating leukodystrophy. Am J Hum Genet. 2011;89(5):652-655. doi: 10.1016/j.ajhg.2011.10.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Thiffault I, Wolf NI, Forget D, et al. Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III. Nat Commun. 2015;6:7623. doi: 10.1038/ncomms8623 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Macintosh J, Perrier S, Pinard M, et al. Biallelic pathogenic variants in POLR3D alter tRNA transcription and cause a hypomyelinating leukodystrophy: a case report. Front Neurol. 2023;14:1254140. doi: 10.3389/fneur.2023.1254140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Dorboz I, Dumay-Odelot H, Boussaid K, et al. Mutation in POLR3 K causes hypomyelinating leukodystrophy and abnormal ribosomal RNA regulation. Neurol Genet. 2018;4(6):e289. doi: 10.1212/NXG.0000000000000289 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Borchert GM, Lanier W, Davidson BL. RNA Polymerase III transcribes human microRNAs. Nat Struct Mol Biol. 2006;13(12):1097-1101. doi: 10.1038/nsmb1167 [DOI] [PubMed] [Google Scholar]
  • 8.Werner M, Thuriaux P, Soutourina J. Structure-function analysis of RNA polymerases I and III. Curr Opin Struct Biol. 2009;19(6):740-745. doi: 10.1016/j.sbi.2009.10.005 [DOI] [PubMed] [Google Scholar]
  • 9.Al Yazidi G, Tran LT, Guerrero K, et al. Dystonia in RNA polymerase III-related leukodystrophy. Mov Disord Clin Pract. 2019;6(2):155-159. doi: 10.1002/mdc3.12715 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Osterman B, Sylvain M, Chouinard S, Bernard G. Tremor-ataxia with central hypomyelination (TACH): dystonia as a new clinical feature. Mov Disord Off J Mov Disord Soc. 2012;27(14):1829-1830. doi: 10.1002/mds.25270 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Wolf NI, Vanderver A, van Spaendonk RML, et al. Clinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutations. Neurology. 2014;83(21):1898-1905. doi: 10.1212/WNL.0000000000001002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gauquelin L, Cayami FK, Sztriha L, et al. Clinical spectrum of POLR3-related leukodystrophy caused by biallelic POLR1C pathogenic variants. Neurol Genet. 2019;5(6):e369. doi: 10.1212/NXG.0000000000000369 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Pelletier F, Perrier S, Cayami FK, et al. Endocrine and growth abnormalities in 4H leukodystrophy caused by variants in POLR3A, POLR3B, and POLR1C. J Clin Endocrinol Metab. 2021;106(2):e660-e674. doi: 10.1210/clinem/dgaa700 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bernard G, Vanderver A. POLR3-Related Leukodystrophy. In: Adam MP, Mirzaa GM, Pagon RA, et al. eds. ,GeneReviews®. University of Washington; 1993:1-20. Accessed May 25, 2023. http://www.ncbi.nlm.nih.gov/books/NBK99167/ [PubMed] [Google Scholar]
  • 15.Harting I, Al-Saady M, Krägeloh-Mann I, et al. POLR3A variants with striatal involvement and extrapyramidal movement disorder. Neurogenetics. 2020;21(2):121-133. doi: 10.1007/s10048-019-00602-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hiraide T, Kubota K, Kono Y, et al. POLR3A variants in striatal involvement without diffuse hypomyelination. Brain Dev. 2020;42(4):363-368. doi: 10.1016/j.braindev.2019.12.012 [DOI] [PubMed] [Google Scholar]
  • 17.Gauquelin L, Tétreault M, Thiffault I, et al. POLR3A variants in hereditary spastic paraplegia and ataxia. Brain. 2018;141(1):e1. doi: 10.1093/brain/awx290 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Perrier S, Gauquelin L, Wambach JA, Bernard G. Distinguishing severe phenotypes associated with pathogenic variants in POLR3A. Am J Med Genet A. 2022;188(2):708-712. doi: 10.1002/ajmg.a.62553 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Perrier S, Gauquelin L, Fallet-Bianco C, et al. Expanding the phenotypic and molecular spectrum of RNA polymerase III–related leukodystrophy. Neurol Genet. 2020;6(3):e425. doi: 10.1212/NXG.0000000000000425 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Dellve L, Samuelsson L, Tallborn A, Fasth A, Hallberg LRM. Stress and well-being among parents of children with rare diseases: a prospective intervention study. J Adv Nurs. 2006;53(4):392-402. doi: 10.1111/j.1365-2648.2006.03736.x [DOI] [PubMed] [Google Scholar]
  • 21.Farmer AY, Lee SK. The effects of parenting stress, perceived mastery, and maternal depression on parent-child interaction. J Soc Serv Res. 2011;37:516-525. doi: 10.1080/01488376.2011.607367 [DOI] [Google Scholar]
  • 22.Kaaresen PI, Rønning JA, Ulvund SE, Dahl LB. A randomized, controlled trial of the effectiveness of an early-intervention program in reducing parenting stress after preterm birth. Pediatrics. 2006;118(1):e9-19. doi: 10.1542/peds.2005-1491 [DOI] [PubMed] [Google Scholar]
  • 23.Sullivan MJL, Adams H, Yamada K, Kubota Y, Ellis T, Thibault P. The relation between perceived injustice and symptom severity in individuals with major depression: a cross-lagged panel study. J Affect Disord. 2020;274:289-297. doi: 10.1016/j.jad.2020.05.129 [DOI] [PubMed] [Google Scholar]
  • 24.Paré C, Thibault P, Côté P, et al. The relationship between level of catastrophizing and mental health comorbidity in individuals with whiplash injuries. Clin J Pain. 2019;35(11):880-886. doi: 10.1097/AJP.0000000000000749 [DOI] [PubMed] [Google Scholar]
  • 25.Yakobov E, Suso-Ribera C, Vrinceanu T, Adams H, Sullivan MJ. Trait perceived injustice is associated with pain intensity and pain behavior in participants undergoing an experimental pain induction procedure. J Pain. 2019;20(5):592-599. doi: 10.1016/j.jpain.2018.11.007 [DOI] [PubMed] [Google Scholar]
  • 26.Hattangadi N, Cost KT, Birken CS, et al. Parenting stress during infancy is a risk factor for mental health problems in 3-year-old children. BMC Public Health. 2020;20(1):1726. doi: 10.1186/s12889-020-09861-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Toledano-Toledano F, Luna D. The psychosocial profile of family caregivers of children with chronic diseases: a cross-sectional study. Biopsychosoc Med. 2020;14:29. doi: 10.1186/s13030-020-00201-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Dunkel-Schetter C, Feinstein LG, Taylor SE, Falke RL. Patterns of coping with cancer. Health Psychol Off J Div Health Psychol Am Psychol Assoc. 1992;11(2):79-87. doi: 10.1037//0278-6133.11.2.79 [DOI] [PubMed] [Google Scholar]
  • 29.Thompson RJ, Mata J, Jaeggi SM, Buschkuehl M, Jonides J, Gotlib IH. Maladaptive coping, adaptive coping, and depressive symptoms: variations across age and depressive state. Behav Res Ther. 2010;48(6):459-466. doi: 10.1016/j.brat.2010.01.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Chabowski M, Jankowska-Polańska B, Lomper K, Janczak D. The effect of coping strategy on quality of life in patients with NSCLC. Cancer Manag Res. 2018;10:4085-4093. doi: 10.2147/CMAR.S175210 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Fairfax A, Brehaut J, Colman I, et al. A systematic review of the association between coping strategies and quality of life among caregivers of children with chronic illness and/or disability. BMC Pediatr. 2019;19(1):215. doi: 10.1186/s12887-019-1587-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Lynch J, D’Alton P, Gaynor K. Evaluating the role of perceived injustice in mental health outcomes in cervical cancer care. Support Care Cancer. 2022;30(7):6215-6223. doi: 10.1007/s00520-022-07060-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Büssing A, Ostermann T, Neugebauer EAM, Heusser P. Adaptive coping strategies in patients with chronic pain conditions and their interpretation of disease. BMC Public Health. 2010;10:507. doi: 10.1186/1471-2458-10-507 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Pinquart M, Shen Y. Behavior problems in children and adolescents with chronic physical illness: a meta-analysis. J Pediatr Psychol. 2011;36(9):1003-1016. doi: 10.1093/jpepsy/jsr042 [DOI] [PubMed] [Google Scholar]
  • 35.Dymecka J, Gerymski R, Tataruch R, Bidzan M. Fatigue, physical disability and self-efficacy as predictors of the acceptance of illness and health-related quality of life in patients with multiple sclerosis. Int J Environ Res Public Health. 2021;18(24):13237. doi: 10.3390/ijerph182413237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Pinquart M. Parenting stress in caregivers of children with chronic physical condition—a meta-analysis. Stress Health. 2018;34(2):197-207. doi: 10.1002/smi.2780 [DOI] [PubMed] [Google Scholar]
  • 37.Miranda RN, Ximenes R, Gebretekle GB, Bielecki JM, Sander B, RADAM-LAC Research Team. Health-related quality of life in neurological disorders most commonly associated with Zika-virus infection: a systematic review. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2020;23(7):969-976. doi: 10.1016/j.jval.2020.03.004 [DOI] [PubMed] [Google Scholar]
  • 38.Mirchi A, Pelletier F, Tran LT, et al. Health-related quality of life for patients with genetically determined leukoencephalopathy. Pediatr Neurol. 2018;84:21-26. doi: 10.1016/j.pediatrneurol.2018.03.015 [DOI] [PubMed] [Google Scholar]
  • 39.Dermer E, Spahr A, Tran LT, et al. Stress in parents of children with genetically determined leukoencephalopathies: a pilot study. J Child Neurol. 2020;35(13):901-907. doi: 10.1177/0883073820938645 [DOI] [PubMed] [Google Scholar]
  • 40.Varni JW, Sherman SA, Burwinkle TM, Dickinson PE, Dixon P. The PedsQLTM family impact module: preliminary reliability and validity. Health Qual Life Outcomes. 2004;2:55. doi: 10.1186/1477-7525-2-55 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Abidin RR. Parenting Stress Index. 2011. Published online September 12, 2011. doi: 10.1037/t02445-000 [DOI] [PubMed]
  • 42.Kyriazos TA, Stalikas A. Positive parenting or positive psychology parenting? Towards a conceptual framework of positive psychology parenting. Psychology. 2018;09(07):1761-1788. doi: 10.4236/psych.2018.97104 [DOI] [Google Scholar]
  • 43.Berry JO, Jones WH. The Parental Stress Scale: Initial psychometric evidence. J Soc Pers Relatsh. 1995;12:463-472. doi: 10.1177/0265407595123009 [DOI] [Google Scholar]
  • 44.McCubbin HI, McCubbin MA, Patterson JM, Cauble AE, Wilson LR, Warwick W. CHIP—Coping Health Inventory for Parents: an assessment of parental coping patterns in the care of the chronically ill child. J Marriage Fam. 1983;45:359-370. doi: 10.2307/351514 [DOI] [Google Scholar]
  • 45.Sullivan MJL, Adams H, Horan S, Maher D, Boland D, Gross R. The role of perceived injustice in the experience of chronic pain and disability: scale development and validation. J Occup Rehabil. 2008;18(3):249-261. doi: 10.1007/s10926-008-9140-5 [DOI] [PubMed] [Google Scholar]
  • 46.Mishra K, Ramachandran S, Firdaus S, Rath B. The impact of pediatric nephrotic syndrome on parents’ health-related quality of life and family functioning: an assessment made by the PedsQL 4.0 Family Impact Module. Saudi J Kidney Dis Transplant Off Publ Saudi Cent Organ Transplant Saudi Arab. 2015;26(2):285-292. doi: 10.4103/1319-2442.152420 [DOI] [PubMed] [Google Scholar]
  • 47.Chandran A, Sikka K, Thakar A, et al. The impact of pediatric tracheostomy on the quality of life of caregivers. Int J Pediatr Otorhinolaryngol. 2021;149:110854. doi: 10.1016/j.ijporl.2021.110854 [DOI] [PubMed] [Google Scholar]
  • 48.Ilkowitz J, Gallagher MP, Lois B, Pacheco ML, Zeleniuch-Jacquotte A. Family Impact Module and type 1 diabetes. Diabetes. 2018;67(Supplement_1):841-P. doi: 10.2337/db18-841-P [DOI] [Google Scholar]
  • 49.Rozensztrauch A, Śmigiel R. Quality of life in children with Prader-Willi syndrome and the impact of the disease on the functioning of families. Int J Environ Res Public Health. 2022;19(23):16330. doi: 10.3390/ijerph192316330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Simpson TS, Grande LA, Kenny JJ, Wilson PE, Peterson RL. Child, parent, and family adjustment for patients followed in a multidisciplinary spina bifida clinic. Top Spinal Cord Inj Rehabil. 2022;28(3):41-58. doi: 10.46292/sci21-00074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Morcov MV, Pădure L, Morcov CG, Mirea A, Ghiță M, Onose G. Comparative analysis of the quality of life in families with children or adolescents having congenital versus acquired neuropathology. Child Basel Switz. 2022;9(5):714. doi: 10.3390/children9050714 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39(4):214-223. doi: 10.1111/j.1469-8749.1997.tb07414.x [DOI] [PubMed] [Google Scholar]
  • 53.Eliasson AC, Krumlinde-Sundholm L, Rösblad B, et al. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol. 2006;48(7):549-554. doi: 10.1017/S0012162206001162 [DOI] [PubMed] [Google Scholar]
  • 54.Sellers D, Mandy A, Pennington L, Hankins M, Morris C. Development and reliability of a system to classify the eating and drinking ability of people with cerebral palsy. Dev Med Child Neurol. 2014;56(3):245-251. doi: 10.1111/dmcn.12352 [DOI] [PubMed] [Google Scholar]
  • 55.Hidecker MJC, Paneth N, Rosenbaum PL, et al. Developing and validating the Communication Function Classification System for individuals with cerebral palsy. Dev Med Child Neurol. 2011;53(8):704-710. doi: 10.1111/j.1469-8749.2011.03996.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Kehrer C, Blumenstock G, Raabe C, Krägeloh-Mann I. Development and reliability of a classification system for gross motor function in children with metachromatic leucodystrophy. Dev Med Child Neurol. 2011;53(2):156-160. doi: 10.1111/j.1469-8749.2010.03821.x [DOI] [PubMed] [Google Scholar]
  • 57.Gavazzi F, Glanzman AM, Woidill S, et al. Exploration of gross motor function in Aicardi Goutières syndrome (AGS). J Child Neurol. 2023;38(8-9):518-527. doi: 10.1177/08830738231188753 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Adang LA, Gavazzi F, Jawad AF, et al. Development of a neurologic severity scale for Aicardi Goutières syndrome. Mol Genet Metab. 2020;130(2):153-160. doi: 10.1016/j.ymgme.2020.03.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Panepinto JA, Hoffmann RG, Pajewski NM. A psychometric evaluation of the PedsQLTM Family Impact Module in parents of children with sickle cell disease. Health Qual Life Outcomes. 2009;7:32. doi: 10.1186/1477-7525-7-32 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Scarpelli AC, Paiva SM, Pordeus IA, Varni JW, Viegas CM, Allison PJ. The Pediatric Quality of Life InventoryTM (PedsQLTM) Family Impact Module: reliability and validity of the Brazilian version. Health Qual Life Outcomes. 2008;6(1):35. doi: 10.1186/1477-7525-6-35 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Algarvio S, Leal I, Maroco J. Parental stress scale: validation study with a Portuguese population of parents of children from 3 to 10 years old. J Child Health Care Prof Work Child Hosp Community. 2018;22(4):563-576. doi: 10.1177/1367493518764337 [DOI] [PubMed] [Google Scholar]
  • 62.Majnemer A, Shevell M, Law M, Poulin C, Rosenbaum P. Indicators of distress in families of children with cerebral palsy. Disabil Rehabil. 2012;34(14):1202-1207. doi: 10.3109/09638288.2011.638035 [DOI] [PubMed] [Google Scholar]
  • 63.Park MS, Chung CY, Lee KM, Sung KH, Choi IH, Kim TW. Parenting stress in parents of children with cerebral palsy and its association with physical function. J Pediatr Orthop Part B. 2012;21(5):452-456. doi: 10.1097/BPB.0b013e32835470c0 [DOI] [PubMed] [Google Scholar]
  • 64.Wirrell EC, Wood L, Hamiwka LD, Sherman EMS. Parenting stress in mothers of children with intractable epilepsy. Epilepsy Behav EB. 2008;13(1):169-173. doi: 10.1016/j.yebeh.2008.02.011 [DOI] [PubMed] [Google Scholar]
  • 65.Cushner-Weinstein S, Dassoulas K, Salpekar JA, et al. Parenting stress and childhood epilepsy: the impact of depression, learning, and seizure-related factors. Epilepsy Behav EB. 2008;13(1):109-114. doi: 10.1016/j.yebeh.2008.03.010 [DOI] [PubMed] [Google Scholar]
  • 66.Bennett E, English MW, Rennoldson M, Starza-Smith A. Predicting parenting stress in caregivers of children with brain tumours. Psychooncology. 2013;22(3):629-636. doi: 10.1002/pon.3047 [DOI] [PubMed] [Google Scholar]
  • 67.Wiltshire JC, Enard KR, Colato EG, Orban BL. Problems paying medical bills and mental health symptoms post-Affordable Care Act. AIMS Public Health. 2020;7(2):274-286. doi: 10.3934/publichealth.2020023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Ryu S, Fan L. The relationship between financial worries and psychological distress among U.S. adults. J Fam Econ Issues. 2023;44(1):16-33. doi: 10.1007/s10834-022-09820-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Salleh Mohd R. Life event, stress and illness. Malays J Med Sci MJMS. 2008;15(4):9-18. [PMC free article] [PubMed] [Google Scholar]
  • 70.Pelentsov LJ, Fielder AL, Laws TA, Esterman AJ. The supportive care needs of parents with a child with a rare disease: results of an online survey. BMC Fam Pract. 2016;17(1):88. doi: 10.1186/s12875-016-0488-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Boettcher J, Boettcher M, Wiegand-Grefe S, Zapf H. Being the pillar for children with rare diseases—a systematic review on parental quality of life. Int J Environ Res Public Health. 2021;18(9):4993. doi: 10.3390/ijerph18094993 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Kolemen AB, Akyuz E, Toprak A, Deveci E, Yesil G. Evaluation of the parents’ anxiety levels before and after the diagnosis of their child with a rare genetic disease: the necessity of psychological support. Orphanet J Rare Dis. 2021;16(1):402. doi: 10.1186/s13023-021-02046-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Thomas PA, Liu H, Umberson D. Family relationships and well-being. Innov Aging. 2017;1(3):1-11. doi: 10.1093/geroni/igx025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Kwon OY, Ahn HS, Kim HJ, Park KW. Effectiveness of cognitive behavioral therapy for caregivers of people with dementia: a systematic review and meta-analysis. J Clin Neurol Seoul Korea. 2017;13(4):394. doi: 10.3988/jcn.2017.13.4.394 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Rice DB, Carboni-Jiménez A, Cañedo-Ayala M, et al. Perceived benefits and facilitators and barriers to providing psychosocial interventions for informal caregivers of people with rare diseases: a scoping review. Patient. 2020;13(5):471-519. doi: 10.1007/s40271-020-00441-8 [DOI] [PubMed] [Google Scholar]
  • 76.Bodenheimer T. Interventions to improve chronic illness care: evaluating their effectiveness. Dis Manag DM. 2003;6(2):63-71. doi: 10.1089/109350703321908441 [DOI] [PubMed] [Google Scholar]
  • 77.Bogart K, Hemmesch A, Barnes E, et al. Healthcare access, satisfaction, and health-related quality of life among children and adults with rare diseases. Orphanet J Rare Dis. 2022;17(1):196. doi: 10.1186/s13023-022-02343-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Chung CCY, Ng NYT, Ng YNC, et al. Socio-economic costs of rare diseases and the risk of financial hardship: a cross-sectional study. Lancet Reg Health West Pac. 2023;34:100711. doi: 10.1016/j.lanwpc.2023.100711 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Child Neurology are provided here courtesy of SAGE Publications

RESOURCES